West Virginia, Mississippi, and Arkansas are the U.S. states with the highest percentage of their population who are obese. The states with the lowest percentage of their population who are obese include Colorado, Hawaii, and Massachusetts. Obesity in the United States Obesity is a growing problem in many countries around the world, but the United States has the highest rate of obesity among all OECD countries. The prevalence of obesity in the United States has risen steadily over the previous two decades, with no signs of declining. Obesity in the U.S. is more common among women than men, and overweight and obesity rates are higher among African Americans than any other race or ethnicity. Causes and health impacts Obesity is most commonly the result of a combination of poor diet, overeating, physical inactivity, and a genetic susceptibility. Obesity is associated with various negative health impacts, including an increased risk of cardiovascular diseases, certain types of cancer, and diabetes type 2. As of 2022, around 8.4 percent of the U.S. population had been diagnosed with diabetes. Diabetes is currently the eighth leading cause of death in the United States.

The prevalence of obesity in the United States has risen gradually over the past decade. As of 2023, around ** percent of the population aged 18 years and older was obese. Obesity is a growing problem in many parts of the world, but is particularly troubling in the United States. Obesity in the United States The states with the highest prevalence of obesity are West Virginia, Mississippi, and Arkansas. As of 2023, a shocking ** percent of the population in West Virginia were obese. The percentage of adults aged 65 years and older who are obese has grown in recent years, compounding health issues that develop with age. Health impacts of obesity Obesity is linked to several negative health impacts including cardiovascular disease, diabetes, and certain types of cancer. Unsurprisingly, the prevalence of diagnosed diabetes has increased in the United States over the years. As of 2022, around *** percent of the population had been diagnosed with diabetes. Some of the most common types of cancers caused by obesity include breast cancer in postmenopausal women, colon and rectum cancer, and corpus and uterus cancer.

In 2022, the U.S. states with the highest rates of obesity among women were Tennessee, Louisiana, and Mississippi. At that time, almost 43 percent of women in Tennessee were considered obese. The states with the highest rates of obesity among men are West Virginia, Kentucky, and Oklahoma. Obesity: Women vs. men As of 2022, women in the United States had slightly higher rates of obesity than men. At that time, around 34.1 percent of women were considered obese, compared to 32.6 percent of men. Rates of obesity among both men and women are higher in the United States than any other OECD country, with high-calorie diets, often from fast food and sugary drinks, and large food portion sizes being partly to blame. In 2023, the mean self-reported weight among men in the United States was 199 pounds, while women reported weighing an average of 164 pounds. Which state is the most obese? As of 2022, West Virginia had the highest prevalence of adult obesity in the United States, with around 41 percent of the population considered obese. Following West Virginia, Louisiana, Oklahoma, and Mississippi, had some of the highest rates of obesity in the country. Colorado had the lowest share of adults who were obese at that time, but still, a quarter of adults in the state were obese. West Virginia is also the state with the highest prevalence of obesity among high school students, with 27 percent of high schoolers considered obese in 2021. Obesity in childhood is associated with obesity as adults, as well as mental health problems such as anxiety and depression.

Obesity has become a major concern for health officials in the United States. Rates of obesity are higher than ever before and as a result, consequential medical conditions have arisen in those who suffer from obesity; while at the same time, medical expenses are skyrocketing for these same individuals. In this study, I analyze regional trends in the United States of both obesity rates and walkability in 74 cities in the United States. After analyzing the data and constructing visual representations, I found that the Northeast region of the US is most walkable, while the Southeast and Southwestern regions are the least walkable. In regards to obesity rates, I found that the West had the lowest obesity rates in both 2010 and 2013, while the Midwest and the Southeast had a high obesity rate in both 2010 and 2013. Additionally, the Northeastern US had a high obesity rate in 2013.

In 2021-2022, Mississippi topped the ranking of states with the highest share of children/adolescents between 6 and 17 years of age who were obese. This statistic illustrates the obesity rates among children/adolescents between 6 and 17 years of age in the United States in 2021-2022, by state.

United States US: Prevalence of Overweight: Weight for Height: Female: % of Children Under 5 data was reported at 6.900 % in 2012. This records an increase from the previous number of 6.400 % for 2009. United States US: Prevalence of Overweight: Weight for Height: Female: % of Children Under 5 data is updated yearly, averaging 6.900 % from Dec 1991 (Median) to 2012, with 6 observations. The data reached an all-time high of 8.700 % in 2005 and a record low of 5.100 % in 1991. United States US: Prevalence of Overweight: Weight for Height: Female: % of Children Under 5 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s USA – Table US.World Bank: Health Statistics. Prevalence of overweight, female, is the percentage of girls under age 5 whose weight for height is more than two standard deviations above the median for the international reference population of the corresponding age as established by the WHO's new child growth standards released in 2006.; ; World Health Organization, Global Database on Child Growth and Malnutrition. Country-level data are unadjusted data from national surveys, and thus may not be comparable across countries.; Linear mixed-effect model estimates; Estimates of overweight children are also from national survey data. Once considered only a high-income economy problem, overweight children have become a growing concern in developing countries. Research shows an association between childhood obesity and a high prevalence of diabetes, respiratory disease, high blood pressure, and psychosocial and orthopedic disorders (de Onis and Blössner 2003). Childhood obesity is associated with a higher chance of obesity, premature death, and disability in adulthood. In addition to increased future risks, obese children experience breathing difficulties and increased risk of fractures, hypertension, early markers of cardiovascular disease, insulin resistance, and psychological effects. Children in low- and middle-income countries are more vulnerable to inadequate nutrition before birth and in infancy and early childhood. Many of these children are exposed to high-fat, high-sugar, high-salt, calorie-dense, micronutrient-poor foods, which tend be lower in cost than more nutritious foods. These dietary patterns, in conjunction with low levels of physical activity, result in sharp increases in childhood obesity, while under-nutrition continues

US: Prevalence of Overweight: Weight for Height: % of Children Under 5 data was reported at 6.000 % in 2012. This records a decrease from the previous number of 7.800 % for 2009. US: Prevalence of Overweight: Weight for Height: % of Children Under 5 data is updated yearly, averaging 7.000 % from Dec 1991 (Median) to 2012, with 5 observations. The data reached an all-time high of 8.100 % in 2005 and a record low of 5.400 % in 1991. US: Prevalence of Overweight: Weight for Height: % of Children Under 5 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s USA – Table US.World Bank: Health Statistics. Prevalence of overweight children is the percentage of children under age 5 whose weight for height is more than two standard deviations above the median for the international reference population of the corresponding age as established by the WHO's new child growth standards released in 2006.; ; UNICEF, WHO, World Bank: Joint child malnutrition estimates (JME). Aggregation is based on UNICEF, WHO, and the World Bank harmonized dataset (adjusted, comparable data) and methodology.; Linear mixed-effect model estimates; Estimates of overweight children are also from national survey data. Once considered only a high-income economy problem, overweight children have become a growing concern in developing countries. Research shows an association between childhood obesity and a high prevalence of diabetes, respiratory disease, high blood pressure, and psychosocial and orthopedic disorders (de Onis and Blössner 2003). Childhood obesity is associated with a higher chance of obesity, premature death, and disability in adulthood. In addition to increased future risks, obese children experience breathing difficulties and increased risk of fractures, hypertension, early markers of cardiovascular disease, insulin resistance, and psychological effects. Children in low- and middle-income countries are more vulnerable to inadequate nutrition before birth and in infancy and early childhood. Many of these children are exposed to high-fat, high-sugar, high-salt, calorie-dense, micronutrient-poor foods, which tend be lower in cost than more nutritious foods. These dietary patterns, in conjunction with low levels of physical activity, result in sharp increases in childhood obesity, while under-nutrition continues

Obesity rate for adults 20+ years old. Data from US Diabetes Surveillance System; www.cdc.gov/diabetes/data; Division of Diabetes Translation - Centers for Disease Control and Prevention. Obesity is defined with BMI >30.

United States Prevalence of Overweight: % of Adults data was reported at 67.900 % in 2016. This records an increase from the previous number of 67.400 % for 2015. United States Prevalence of Overweight: % of Adults data is updated yearly, averaging 55.200 % from Dec 1975 (Median) to 2016, with 42 observations. The data reached an all-time high of 67.900 % in 2016 and a record low of 41.000 % in 1975. United States Prevalence of Overweight: % of Adults data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s United States – Table US.World Bank.WDI: Social: Health Statistics. Prevalence of overweight adults is the percentage of adults ages 18 and over whose Body Mass Index (BMI) is more than 25 kg/m2. Body Mass Index (BMI) is a simple index of weight-for-height, or the weight in kilograms divided by the square of the height in meters.;World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/).;;

This report presents information on obesity, physical activity and diet drawn together from a variety of sources for England. More information can be found in the source publications which contain a wider range of data and analysis. Each section provides an overview of key findings, as well as providing links to relevant documents and sources. Some of the data have been published previously by NHS Digital. A data visualisation tool (link provided within the key facts) allows users to select obesity related hospital admissions data for any Local Authority (as contained in the data tables), along with time series data from 2013/14. Regional and national comparisons are also provided. The report includes information on: Obesity related hospital admissions, including obesity related bariatric surgery. Obesity prevalence. Physical activity levels. Walking and cycling rates. Prescriptions items for the treatment of obesity. Perception of weight and weight management. Food and drink purchases and expenditure. Fruit and vegetable consumption. Key facts cover the latest year of data available: Hospital admissions: 2018/19 Adult obesity: 2018 Childhood obesity: 2018/19 Adult physical activity: 12 months to November 2019 Children and young people's physical activity: 2018/19 academic year

Surveys comparing obesity rates among adults in the United States in 2019 and 2023 revealed that both years presented similar trends. Adults aged 45–65 years old had the highest obesity rates in both years. Additionally, obesity rates increased across all age groups in 2023 compared to 2019. This statistic depicts the percentage of adults in the United States with obesity in 2019 and 2023, by age.

This data represents the age-adjusted prevalence of high total cholesterol, hypertension, and obesity among US adults aged 20 and over between 1999-2000 to 2017-2018. Notes: All estimates are age adjusted by the direct method to the U.S. Census 2000 population using age groups 20–39, 40–59, and 60 and over. Definitions Hypertension: Systolic blood pressure greater than or equal to 130 mmHg or diastolic blood pressure greater than or equal to 80 mmHg, or currently taking medication to lower high blood pressure High total cholesterol: Serum total cholesterol greater than or equal to 240 mg/dL. Obesity: Body mass index (BMI, weight in kilograms divided by height in meters squared) greater than or equal to 30. Data Source and Methods Data from the National Health and Nutrition Examination Surveys (NHANES) for the years 1999–2000, 2001–2002, 2003–2004, 2005–2006, 2007–2008, 2009–2010, 2011–2012, 2013–2014, 2015–2016, and 2017–2018 were used for these analyses. NHANES is a cross-sectional survey designed to monitor the health and nutritional status of the civilian noninstitutionalized U.S. population. The survey consists of interviews conducted in participants’ homes and standardized physical examinations, including a blood draw, conducted in mobile examination centers.

Note: This data was created by the Center for Disease Control, not the City of Rochester. This map is zoomed in to show the CDC data at the census tract level. You can zoom out to see data for all 500 cities in the data set. This map has been built to symbolize the percentage of adults who, in 2017, had a body mass index (BMI) at/above 30.0, classifying them as obese according to self-reported data on their height on weight. However, if you click on a census tract, you can see statistics for the other public health statistics mentioned below in the "Overview of the Data" section.Overview of the Data: This service provides the 2019 release for the 500 Cities Project, based on data from 2017 or 2016 model-based small area estimates for 27 measures of chronic disease related to unhealthy behaviors (5), health outcomes (13), and use of preventive services (9). Twenty measures are based on 2017 Behavioral Risk Factor Surveillance System (BRFSS) model estimates. Seven measures (all teeth lost, dental visits, mammograms, Pap tests, colorectal cancer screening, core preventive services among older adults, and sleep less than 7 hours) kept 2016 model estimates, since those questions are only asked in even years. The project was funded by the Robert Wood Johnson Foundation (RWJF) in conjunction with the CDC Foundation. It represents a first-of-its kind effort to release information on a large scale for cities and for small areas within those cities. It includes estimates for the 500 largest US cities and approximately 28,000 census tracts within these cities. These estimates can be used to identify emerging health problems and to inform development and implementation of effective, targeted public health prevention activities. Because the small area model cannot detect effects due to local interventions, users are cautioned against using these estimates for program or policy evaluations.Data were provided by the Centers for Disease Control and Prevention (CDC), Division of Population Health, Epidemiology and Surveillance Branch. Data sources used to generate these measures include BRFSS data (2017 or 2016), Census Bureau 2010 census population data, and American Community Survey (ACS) 2013-2017 or 2012-2016 estimates. For more information about the methodology, visit https://www.cdc.gov/500cities or contact 500Cities@cdc.gov.

The pediatric obesity management market is experiencing robust growth, driven by rising childhood obesity rates globally and increasing awareness of associated health risks. The market size in 2025 is estimated at $15 billion, exhibiting a Compound Annual Growth Rate (CAGR) of 7% from 2025 to 2033, projecting a market value exceeding $25 billion by 2033. This growth is fueled by several key factors: an increase in sedentary lifestyles among children, changing dietary habits with higher consumption of processed foods and sugary drinks, and a lack of access to adequate healthcare and nutritional education in many regions. Furthermore, advancements in obesity management treatments, including pharmaceuticals, bariatric surgery (where applicable and ethically sound), and technological solutions for weight management and monitoring, are further accelerating market expansion. Significant market segmentation exists based on treatment type (pharmaceutical interventions, behavioral therapies, surgical procedures, and digital health solutions), age group, and geographic region. North America currently holds the largest market share due to high obesity prevalence and advanced healthcare infrastructure. However, Asia-Pacific is expected to witness significant growth over the forecast period due to rising disposable incomes, increased awareness of obesity-related complications, and expanding healthcare sectors. Restraints to market growth include high treatment costs, limited access to specialized care in developing countries, and concerns regarding long-term efficacy and potential side effects of certain interventions. Nevertheless, the market's overall trajectory indicates strong potential for continued expansion, with a focus on developing affordable and accessible solutions tailored to diverse populations.

Obese Patient Trolley Market Outlook

The global market size for obese patient trolleys is projected to grow significantly from $350 million in 2023 to approximately $600 million by 2032, exhibiting a robust CAGR of 6.3%. The increasing prevalence of obesity, coupled with the rising demand for specialized medical equipment to ensure the safe transport of obese patients, is driving this market's growth. Innovations in trolley design and materials, coupled with increased healthcare spending, are also contributing factors to this upward trend.

The significant growth in the obese patient trolley market can be attributed to a myriad of factors. Primarily, the rising incidence of obesity worldwide has necessitated the need for specialized medical equipment. According to the World Health Organization (WHO), obesity has nearly tripled since 1975, with over 650 million adults classified as obese in 2016. This alarming trend has led to an increased demand for obese patient trolleys, which are specifically designed to safely transport overweight and obese patients, ensuring their comfort and reducing the risk of injury to both the patient and healthcare providers. The growing awareness and emphasis on patient safety and mobility have further accentuated the need for these specialized trolleys.

Technological advancements and innovations in the design of obese patient trolleys are another critical growth factor. Modern trolleys are equipped with features such as electric and hydraulic adjustment systems, advanced braking mechanisms, and enhanced weight-bearing capacities. These innovations not only improve the safety and comfort of obese patients but also enhance the efficiency and ease of use for healthcare providers. Additionally, the integration of lightweight yet durable materials, such as high-grade aluminum and stainless steel, has resulted in trolleys that are both robust and easy to maneuver. These advancements have led to increased adoption of obese patient trolleys across various healthcare settings, further driving market growth.

Moreover, the increased healthcare expenditure and the growing number of healthcare facilities globally are contributing to the market's expansion. Governments and private healthcare providers are investing heavily in modernizing their medical infrastructure to cater to the needs of an increasingly obese population. This includes the procurement of specialized medical equipment such as obese patient trolleys. Additionally, the rise in the number of bariatric surgeries and other medical procedures that require the safe transport of obese patients is further fueling the demand for these trolleys. The growing focus on enhancing patient care and safety standards is expected to continue driving market growth in the coming years.

Analyzing the regional outlook, North America is expected to remain the dominant market for obese patient trolleys, largely due to the high prevalence of obesity and the advanced healthcare infrastructure in the region. The United States, in particular, has one of the highest obesity rates globally, which has led to a significant demand for specialized medical equipment. Europe is also anticipated to witness substantial growth, driven by the increasing focus on patient safety and the rising investments in healthcare infrastructure. The Asia Pacific region is projected to exhibit the highest CAGR, primarily due to the growing healthcare expenditure, the rising incidence of obesity, and the increasing adoption of advanced medical technologies in countries such as China and India.

In the context of specialized medical equipment, the Overweight Patient Tilt Table emerges as a crucial innovation for healthcare providers. This equipment is designed to safely and effectively manage the positioning and movement of overweight patients, particularly in scenarios where precise positioning is critical, such as during diagnostic procedures or rehabilitation sessions. The tilt table offers adjustable angles and secure support, ensuring patient comfort and safety while minimizing the risk of injury to both patients and healthcare staff. As the prevalence of obesity continues to rise, the demand for such specialized equipment is expected to grow, highlighting the importance of integrating advanced solutions like the Overweight Patient Tilt Table into healthcare settings.

Product Type Analysis

The obese patient trolley market can be segmented into three primary product types: manual trolleys, electric

The global obesity treatment market is experiencing robust growth, projected to reach $5609.9 million in 2025 and maintain a Compound Annual Growth Rate (CAGR) of 12.8% from 2025 to 2033. This significant expansion is driven by several key factors. Rising global obesity prevalence, fueled by increasingly sedentary lifestyles and diets high in processed foods, creates a substantial and growing demand for effective treatment options. Technological advancements in surgical and implant devices, along with the development of more effective medications and dietary therapies, are further contributing to market growth. The market is segmented by treatment type (Surgical & Implant Devices, Medication Therapy, Dietary, Other) and patient application (Children, Adults), reflecting the diverse approaches and target demographics within the obesity treatment landscape. North America currently holds a significant market share due to high obesity rates and advanced healthcare infrastructure, but other regions, particularly Asia Pacific, are showing promising growth potential, driven by increasing awareness and adoption of obesity treatment strategies. The presence of established pharmaceutical companies alongside specialized medical device manufacturers indicates a competitive market landscape characterized by ongoing innovation and market consolidation. The market's continued expansion is expected to be influenced by several factors. Increased government initiatives and public health campaigns aimed at raising awareness about obesity and promoting healthy lifestyles will likely contribute to market growth. However, high treatment costs and potential side effects associated with some therapies pose challenges. Furthermore, the long-term efficacy and adherence to treatment plans can significantly impact the overall market trajectory. The market's future will be shaped by the ongoing development of novel therapies, improvements in access to affordable and effective treatments, and advancements in personalized medicine tailored to individual patient needs and characteristics. The competitive landscape is expected to remain dynamic, with existing players continually investing in research and development and new entrants emerging with innovative solutions.

For more recent aggregated data reports on childhood obesity in NM, visit NM Healthy Kids Healthy Communities Program, NMDOH: https://www.nmhealth.org/about/phd/pchb/hknm/TitleChildhood Obese and Overweight Estimates, NM Counties 2016 - NMCHILDOBESITY2017SummaryCounty level childhood overweight and obese estimates for 2016 in New Mexico. *Most recent data known to be available on childhood obesity*NotesThis map shows NM County estimated rates of childhood overweight and obesity. US data is available upon request. Published in May, 2022. Data is most recent known sub-national obesity data set. If you know of another resource or more recent, please reach out. emcrae@chi-phi.orgSourceData set produced from the American Journal of Epidemiology and with authors and contributors out of the University of South Carolina, using data from the National Survey of Children's Health. Journal SourceZgodic, A., Eberth, J. M., Breneman, C. B., Wende, M. E., Kaczynski, A. T., Liese, A. D., & McLain, A. C. (2021). Estimates of childhood overweight and obesity at the region, state, and county levels: A multilevel small-area estimation approach. American Journal of Epidemiology, 190(12), 2618–2629. https://doi.org/10.1093/aje/kwab176 Journal article uses data fromThe United States Census Bureau, Associate Director of Demographic Programs, National Survey of Children’s Health 2020 National Survey of Children's Health Frequently Asked Questions. October 2021. Available from:https://www.census.gov/programs-surveys/nsch/data/datasets.htmlGIS Data Layer prepared byEMcRae_NMCDCFeature Servicehttps://nmcdc.maps.arcgis.com/home/item.html?id=80da398a71c14539bfb7810b5d9d5a99AliasDefinitionregionRegion NationallystateState (data set is NM only but national data is available upon request)fips_numCounty FIPScountyCounty NamerateRate of Obesitylower_ciLower Confidence Intervalupper_ciUpper Confidence IntervalfipstxtCounty FIPS text

Number and percentage of adults who reported being overweight or obese, by age group and sex.

Overweight Patient Tilt Table Market Outlook

The global overweight patient tilt table market size is projected to grow from USD 500 million in 2023 to USD 750 million by 2032, registering a compound annual growth rate (CAGR) of 4.5% during the forecast period. The primary growth factors for this market include the increasing prevalence of obesity and related health complications, advancements in medical technology, and rising awareness about the benefits of tilt table therapy for overweight patients.

One of the significant growth drivers for the overweight patient tilt table market is the rising incidence of obesity worldwide. The World Health Organization (WHO) estimates that obesity has nearly tripled since 1975, with over 650 million adults classified as obese in 2016. This increase in obesity rates has led to a higher demand for specialized medical equipment, such as tilt tables, to assist in the treatment and rehabilitation of overweight patients. Additionally, the growing awareness of the health risks associated with obesity, including cardiovascular diseases, diabetes, and musculoskeletal disorders, has further fueled the demand for tilt tables.

Advancements in medical technology have also played a crucial role in driving the growth of the overweight patient tilt table market. Innovations in tilt table design and functionality, such as motorized tilt tables with enhanced safety features and adjustable settings, have made these devices more effective and user-friendly. These advancements have improved patient outcomes and increased the adoption of tilt tables in various healthcare settings. Furthermore, the integration of digital monitoring systems and data analytics in modern tilt tables has enabled healthcare providers to track patient progress and tailor treatment plans more effectively.

The increasing focus on rehabilitation and physiotherapy for overweight patients is another key factor contributing to the market's growth. Tilt table therapy has been proven to offer numerous benefits for obese patients, including improved circulation, enhanced muscle strength, and better postural control. As a result, there has been a growing recognition of the importance of incorporating tilt table therapy into comprehensive treatment plans for overweight patients. This has led to a higher demand for tilt tables in rehabilitation centers, hospitals, and clinics worldwide.

In addition to tilt tables, the use of specialized equipment like the Overweight Patient Wheelchair has become increasingly important in the healthcare sector. These wheelchairs are designed to accommodate the unique needs of overweight patients, offering enhanced support and comfort. They are equipped with features such as reinforced frames, wider seats, and adjustable components to ensure safety and ease of mobility for patients with higher body weights. As the prevalence of obesity continues to rise, the demand for such specialized wheelchairs is expected to grow, providing essential assistance in both clinical and home settings. The integration of these wheelchairs into patient care plans not only improves mobility but also enhances the overall quality of life for overweight individuals.

Regionally, North America holds the largest share of the overweight patient tilt table market, driven by the high prevalence of obesity in the region and the presence of advanced healthcare infrastructure. The United States, in particular, has one of the highest obesity rates globally, with the Centers for Disease Control and Prevention (CDC) reporting that nearly 42.4% of American adults were obese in 2017-2018. This has resulted in a significant demand for specialized medical equipment, including tilt tables, to cater to the needs of overweight patients. Additionally, the availability of government funding and supportive healthcare policies in North America further supports market growth.

Product Type Analysis

In the overweight patient tilt table market, product type is a crucial segment that includes manual tilt tables and motorized tilt tables. Manual tilt tables are typically operated using a lever or crank mechanism, allowing healthcare providers to control the table's tilt angle manually. These tables are relatively cost-effective and do not require an external power source, making them suitable for use in various healthcare settings, including clinics and smaller hospitals. However, manual tilt tables may require more physical effort to operate and may not offer the sam

Weight loss service providers confront intense competition in a highly saturated and concentrated business environment. Proprietary diet plans have existed for decades, with significant industry players established as far back as the early 1960s. Company performance is influenced by domestic population growth, favorable economic conditions and health factors (obesity rate, healthy eating index). Despite the favorable economic conditions following COVID-19, competition from substitutes has stolen consumers. Industry-wide revenue declined at a CAGR of 2.9% to $3.5 billion, falling 0.1% in 2024 alone. As a result, industry profit declined at a similar rate throughout 2024. COVID-19 spurred consolidation and concentration. Larger firms were able to weather the downturn, and smaller establishments exited. Additionally, COVID-19 changed consumers' attitudes toward remote communications. Even though weight loss services have been traditionally in-person, lockdowns changed attitudes. Platforms and mobile technology enabled consumers to engage with others in new novel ways, changing the need for in-person service. Going forward, the continued emphasis on digital platforms will amplify competitive advantages for the most prominent weight loss service providers, causing many more small-scale companies to exit. Yet, regions like the Southeast with a significant obese population will be better served by larger enterprises that can provide better analytics and sophisticated communication modalities. Dominant enterprises may expand, gaining new revenue streams through acquisitions to better meet out-of-market competition products and services (Fitbit, Smartphone apps, social media groups, VR chat rooms.) Nevertheless, revenue will decline at a CAGR of 0.4% to $3.4 billion through the end of 2029.